Drug Type Radiolabeled antibody, Therapeutic radiopharmaceuticals |
Synonyms |
Target |
Mechanism αvβ6 modulators(Integrin alpha-V/beta-6 modulators), Ionising radiation emitters |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | US | 09 Apr 2024 |